انكريسينك 25/45 مجم 7 اقراص

ما هو دواء انكريسينك 25/45 مجم 7 اقراص

جرعة دواءانكريسينك 25/45 مجم 7 اقراص

يستعمل دواء انكريسينك 25/45 مجم 7 اقراصincresync 25/45 mg 7 tabs. anti-diabetic.insulin sensitizers with dpp-4 inhibitor anti-diabetic.insulin sensitizers with dpp-4 inhibitor

it is used as an addition to diet and exercise in adults with type-2 diabetes to improve the control of blood glucose (sugar) levels: - -*in patients who are not satisfactorily controlled with pioglitazone alone and who cannot be treated with metformin (another diabetes medicine); -*together with metformin in patients who are not satisfactorily controlled with a combination of pioglitazone and metformin. - -alogliptin is a dipeptidyl-peptidase-4 (dpp 4) inhibitor. it works by blocking the breakdown of �incretin� hormones in the body. these hormones are released after a meal and stimulate the pancreas to produce insulin. - -pioglitazone makes cells (fat muscle and liver) more sensitive to insulin which means that the body makes better use of the insulin it produces.

تركيبة دواءانكريسينك 25/45 مجم 7 اقراصincresync 25/45 mg 7 tabs.

يتركب هذا الدواء من :alogliptin+pioglitazone